The Journal of
Clinical Psychiatry

Volume 64 • 2003 • 10

Brainstorms

Deconstructing Psychiatric Disorders, Part 2: An Emerging, Neurobiologically Based Therapeutic Strategy for the Modern Psychopharmacologist

J Clin Psychiatry 2003;64(10):1145-1146

Stephen M. Stahl, MD, PhD

Original Research

Are Antidepressants Carcinogenic? A Review of Preclinical and Clinical Studies

J Clin Psychiatry 2003;64(10):1153-1162

Harvey Sternbach, MD

Original Research

Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Velocardiofacial Syndrome: An Open-Label Study

J Clin Psychiatry 2003;64(10):1163-1169

Doron Gothelf, MD ; Reut Gruber, PhD ; Gadi Presburger, MA ; Inbar Dotan, MD ; Ayelet Brand-Gothelf, MD ; Merav Burg, MA ; Dov Inbar, MD ; Tamar Steinberg, MD ; Amos Frisch, PhD ; Alan Apter, MD ; Abraham Weizman, MD

Original Research

Occult Mood Disorders in 104 Consecutively Presenting Children Referred for the Treatment of Attention-Deficit/Hyperactivity Disorder in a Community Mental Health Clinic.

J Clin Psychiatry 2003;64(10):1170-1176

Steven C. Dilsaver, MD ; Susan Henderson-Fuller, LMSW-ACP ; Hagop S. Akiskal, MD

Original Research

Sexual Satisfaction and Risk of Disability in Older Women

J Clin Psychiatry 2003;64(10):1177-1182

Graziano Onder, MD, PhD ; Brenda W. J. H. Penninx, Phd ; Jack M. Guralnik, MD, PhD ; Heather Jones, MD ; Linda P. Fried, MD, MPH ; Marco Pahor, MD ; Jeff D. Williamson, MD, MPH

Original Research

Divalproex Sodium for the Treatment of Conduct Disorder: A Randomized Controlled Clinical Trial

J Clin Psychiatry 2003;64(10):1183-1191

Hans Steiner, MD ; Maya L. Petersen, BA ; Kirti Saxena, MD ; Sekou Ford, MD ; Zakee Matthews, MD

Original Research

High-Dose Olanzapine and Prolactin Levels

J Clin Psychiatry 2003;64(10):1192-1194

James L. Karagianis, MD, FRCPC ; Anton Baksh, MD, FRCPC

Original Research

The Effects of Breathing-Related Sleep Disorders on Mood Disturbances in the General Population

J Clin Psychiatry 2003;64(10):1195-1200

Maurice M. Ohayon, MD, DSc, PhD

Original Research

Economic Consequences of Not Recognizing Bipolar Disorder Patients: A Cross-Sectional Descriptive Analysis

J Clin Psychiatry 2003;64(10):1201-1209

Howard G. Birnbaum, PhD ; Lizheng Shi, PdD ; Ellison Dial, BS ; Emily F. Oster, BA ; Paul E. Greenberg, MS, MA ; David A. Mallett, BA

Original Research

The Impact of Attempted Suicide on the Symptoms and Course of Mood Disorders

J Clin Psychiatry 2003;64(10):1210-1216

Kaoru Sakamoto, MD, PhD ; Takako Fukunaga, MD, PhD

Original Research

Trajectories of Posttraumatic Stress Disorder Following Myocardial Infarction: A Prospective Study

J Clin Psychiatry 2003;64(10):1217-1223

Karni Ginzburg, PhD ; Zahava Solomon, PhD ; Bella Koifman, MD ; Gad Keren, MD ; Arie Roth, MD ; Michael Kriwisky, MD ; Ilan Kutz, MD ; Daniel David, MD ; Avi Bleich, MD

Original Research

Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia

J Clin Psychiatry 2003;64(10):1224-1229

Andrew Winokur, MD, PhD ; Nicholas A. DeMartinis III, MD ; Daniel P. McNally, MD ; Ellen M. Gary, BSN ; Jennifer L. Cormier, MS ; Keith A. Gary, PhD

Original Research

Mental Health Treatment Received by Primary Care Patients With Posttraumatic Stress Disorder

J Clin Psychiatry 2003;64(10):1230-1236

Benjamin F. Rodriguez, PhD ; Risa B. Weisberg, PhD ; Maria E. Pagano, PhD ; Jason T. Machan, PhD ; Larry Culpepper, MD, MPH ; Martin B. Keller, MD

Original Research

Duloxetine in the Long-Term Treatment of Major Depressive Disorder

J Clin Psychiatry 2003;64(10):1237-1244

Joel Raskin, MD ; David J. Goldstein, MD, PhD ; Craig H. Mallinckrodt, PhD ; Margaret B. Ferguson, PharmD

Original Research

Tiagabine for the Treatment of Generalized Anxiety Disorder: A Randomized, Open-Label, Clinical Trial With Paroxetine as a Positive Control

J Clin Psychiatry 2003;64(10):1245-1249

Murray Rosenthal, DO

Original Research

Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic

J Clin Psychiatry 2003;64(10):1250-1257

W. Wolfgang Fleischhacker, MD ; Mariëlle Eerdekens, MD ; Keith Karcher, MS ; Gary Remington, MD, PhD ; Wlodzimierz Chrzanowski, MD ; Stephen Martin, MD ; Ola Gefvert, MD

Original Research

Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial

J Clin Psychiatry 2003;64(10):1258-1265

David S. Janowsky, MD ; L. Jarrett Barnhill, MD ; John M. Davis, MD

Commentary

The Dilemma of Unmodified Electroconvulsive Therapy

J Clin Psychiatry 2003;64(10):1147-1152

Chittaranjan Andrade, MD ; Nilesh Shah, DPM, MD, DNB ; Prathap Tharyan, MD, MRCPsych

Letter to the Editor

Divalproex Versus Olanzapine in Mania

J Clin Psychiatry 2003;64(10):1266-1267

Eduard Vieta, MD, PhD

Letter to the Editor

Reply to Divalproex Versus Olanzapine in Mania

J Clin Psychiatry 2003;64(10):1266-1267

John M. Zajecka, MD

Letter to the Editor

Worsening of Psychosis After Replacement of Adjunctive Valproate With Topiramate in a Schizophrenia Patient

J Clin Psychiatry 2003;64(10):1267-1268

Alex Hofer, MD ; W. Wolfgang Fleischhacker, MD ; Martina Hummer, MD

Letter to the Editor

Effect of Bupropion on Sexual Dysfunction Induced by Fluoxetine: A Case Report of Hypersexuality

J Clin Psychiatry 2003;64(10):1268-1269

Carlos A. S. Chollet, MD ; Roberto Andreatini, MD, PhD

Letter to the Editor

A Word of Caution About the Implied Role for Duloxetine in Pain Management

J Clin Psychiatry 2003;64(10):1270-1270

Raphael J. Leo, MD, FAPM

Book Review

Personality Disorders Over Time: Precusrors, Course, and Outcome

J Clin Psychiatry 2003;64(10):1271-1271

James W. Lomax, MD

Book Review

Retrosprective Assessmentof Mental States In Litigation: Predicting the Past

J Clin Psychiatry 2003;64(10):1271-1272

William M. Regan, MD

Book Review

Manual of Psychiatric Therapeutics, 3rd Ed

J Clin Psychiatry 2003;64(10):1272-1272

Authur M. Freeman, MD

Book Review

Treament of Stress Response Syndromes

J Clin Psychiatry 2003;64(10):1272-1273

George E. Vaillant, MD

Volume 64 • 2003 • 10

Brainstorms

Deconstructing Psychiatric Disorders, Part 2: An Emerging, Neurobiologically Based Therapeutic Strategy for the Modern Psychopharmacologist

Original Research

Are Antidepressants Carcinogenic? A Review of Preclinical and Clinical Studies

Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Velocardiofacial Syndrome: An Open-Label Study

Occult Mood Disorders in 104 Consecutively Presenting Children Referred for the Treatment of Attention-Deficit/Hyperactivity Disorder in a Community Mental Health Clinic.

Sexual Satisfaction and Risk of Disability in Older Women

Divalproex Sodium for the Treatment of Conduct Disorder: A Randomized Controlled Clinical Trial

High-Dose Olanzapine and Prolactin Levels

The Effects of Breathing-Related Sleep Disorders on Mood Disturbances in the General Population

Economic Consequences of Not Recognizing Bipolar Disorder Patients: A Cross-Sectional Descriptive Analysis

The Impact of Attempted Suicide on the Symptoms and Course of Mood Disorders

Trajectories of Posttraumatic Stress Disorder Following Myocardial Infarction: A Prospective Study

Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia

Mental Health Treatment Received by Primary Care Patients With Posttraumatic Stress Disorder

Duloxetine in the Long-Term Treatment of Major Depressive Disorder

Tiagabine for the Treatment of Generalized Anxiety Disorder: A Randomized, Open-Label, Clinical Trial With Paroxetine as a Positive Control

Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic

Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial

Commentary

The Dilemma of Unmodified Electroconvulsive Therapy

Letter to the Editor

Divalproex Versus Olanzapine in Mania

Reply to Divalproex Versus Olanzapine in Mania

Worsening of Psychosis After Replacement of Adjunctive Valproate With Topiramate in a Schizophrenia Patient

Effect of Bupropion on Sexual Dysfunction Induced by Fluoxetine: A Case Report of Hypersexuality

A Word of Caution About the Implied Role for Duloxetine in Pain Management

Book Review

Personality Disorders Over Time: Precusrors, Course, and Outcome

Retrosprective Assessmentof Mental States In Litigation: Predicting the Past

Manual of Psychiatric Therapeutics, 3rd Ed

Treament of Stress Response Syndromes

ELSEWHERE:

FOLLOW US:

Volume 64 • 2003 • 10

Brainstorms

Deconstructing Psychiatric Disorders, Part 2: An Emerging, Neurobiologically Based Therapeutic Strategy for the Modern Psychopharmacologist

Original Research

Are Antidepressants Carcinogenic? A Review of Preclinical and Clinical Studies

Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents With Velocardiofacial Syndrome: An Open-Label Study

Occult Mood Disorders in 104 Consecutively Presenting Children Referred for the Treatment of Attention-Deficit/Hyperactivity Disorder in a Community Mental Health Clinic.

Sexual Satisfaction and Risk of Disability in Older Women

Divalproex Sodium for the Treatment of Conduct Disorder: A Randomized Controlled Clinical Trial

High-Dose Olanzapine and Prolactin Levels

The Effects of Breathing-Related Sleep Disorders on Mood Disturbances in the General Population

Economic Consequences of Not Recognizing Bipolar Disorder Patients: A Cross-Sectional Descriptive Analysis

The Impact of Attempted Suicide on the Symptoms and Course of Mood Disorders

Trajectories of Posttraumatic Stress Disorder Following Myocardial Infarction: A Prospective Study

Comparative Effects of Mirtazapine and Fluoxetine on Sleep Physiology Measures in Patients With Major Depression and Insomnia

Mental Health Treatment Received by Primary Care Patients With Posttraumatic Stress Disorder

Duloxetine in the Long-Term Treatment of Major Depressive Disorder

Tiagabine for the Treatment of Generalized Anxiety Disorder: A Randomized, Open-Label, Clinical Trial With Paroxetine as a Positive Control

Treatment of Schizophrenia With Long-Acting Injectable Risperidone: A 12-Month Open-Label Trial of the First Long-Acting Second-Generation Antipsychotic

Olanzapine for Self-Injurious, Aggressive, and Disruptive Behaviors in Intellectually Disabled Adults: A Retrospective, Open-Label, Naturalistic Trial

Commentary

The Dilemma of Unmodified Electroconvulsive Therapy

Letter to the Editor

Divalproex Versus Olanzapine in Mania

Reply to Divalproex Versus Olanzapine in Mania

Worsening of Psychosis After Replacement of Adjunctive Valproate With Topiramate in a Schizophrenia Patient

Effect of Bupropion on Sexual Dysfunction Induced by Fluoxetine: A Case Report of Hypersexuality

A Word of Caution About the Implied Role for Duloxetine in Pain Management

Book Review

Personality Disorders Over Time: Precusrors, Course, and Outcome

Retrosprective Assessmentof Mental States In Litigation: Predicting the Past

Manual of Psychiatric Therapeutics, 3rd Ed

Treament of Stress Response Syndromes

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles